All ITT patients | Patients with HBV DNA level <300 copies/mL at Week 24 | |||
---|---|---|---|---|
Characteristic | HBeAg-positive (n = 16) | HBeAg-negative (n = 25) | HBeAg-positive (n = 7) | HBeAg-negative (n = 16) |
HBV DNA level | ||||
<300 copies/mL, n (%) | 8/16 (50.0) | 19/25 (76.0) | 7/7 (100.0) | 11/16 (78.3) |
ALT normalization, n (%) | 9/16 (56.3) | 20/24 (83.0) | 5/7 (71.4) | 11/15 (86.4) |
HBeAg loss, n (%) | 6/16 (37.5) | NA | 6/7 (85.7) | NA |
HBeAg seroconversion, n (%) | 4/16 (25) | NA | 4/7 (57.1) | NA |
Resistance, n (%) | 7/16 (43.8) | 3/24 (12.5) | 0/7 (0.0) | 2/23 (8.7) |